ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2022
Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- A mixed-methods approach to understanding pharmacists' experiences with the CANRISK diabetes risk questionnaire and user guide.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2026Article
- Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Association between a clinical pharmacist-led multimodal remote medication intervention and individualized treatment outcomes in patients with type 2 diabetes mellitus.Frontiers in endocrinology · 2026Article
- Diabetes risk assessment in Polish community pharmacies. Results from a pilot national screening campaign.Archives of medical science : AMS · 2026Article
- Socio-Demographic, Environmental, and Clinical Factors Influencing Diabetes Mellitus Control in Community Pharmacies of Lahore Pakistan.Healthcare (Basel, Switzerland) · 2025Article
- Effectiveness of Continuous Glucose Monitoring in a Pharmacist-Run Collaborative Drug Therapy Management Service for Underserved Individuals With Diabetes: A Quasi-Experimental Study.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- Pharmacist-Led Digital Health Interventions for Patients with Diabetes: A Systematic Review.Journal of multidisciplinary healthcare · 2025Review
- Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services.Journal of the American College of Clinical Pharmacy : JACCP · 2025Article
- Impact of Pharmacist Interventions on Health Outcomes of Patients with Type 2 Diabetes Mellitus in the Middle East: A Systematic Review.Integrated pharmacy research & practice · 2025Review
- Retrospective Cohort Study Comparing Pharmacist-Primary Care Provider Collaborative Practice to Usual Care for Diabetes Control in a Family Medicine Clinic.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- Overcoming therapeutic inertia in newly diagnosed type 2 diabetes: Protocol of a randomized, quality improvement trial.Contemporary clinical trials · 2025Article
- Novel Pharmacy Model: Pharmacy Diabetes Clinic in Abdominal Transplant Recipients.Diabetes spectrum : a publication of the American Diabetes Association · 2024Article
- The Pharmacy of the Future: Pharmacy Professionals' Perceptions and Contributions Regarding New Services in Community Pharmacies.Healthcare (Basel, Switzerland) · 2023Article
- Impact of Ambulatory Care Pharmacist-Led Management on Hemoglobin A1c Values among Patients with Uncontrolled Diabetes in a Primary Care Clinic vs Usual Care over Two Years.Innovations in pharmacy · 2023Article
- Functions of mHealth Diabetes Apps That Enable the Provision of Pharmaceutical Care: Criteria Development and Evaluation of Popular Apps.International journal of environmental research and public health · 2022Article
- Diabetes Management: A Case Study to Drive National Policy Change in Primary Care Settings.Annals of family medicineArticle
- Evaluating Pharmacotherapy Optimization in Pharmacist-Led Management of Type 2 Diabetes Utilizing Continuous Glucose Monitors.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The health and economic burden of diabetes mellitus across the United States and the world is such that effective care is crucial to improving outcomes, including macro and microvascular complications, and lowering health care costs. Pharmacists are well placed within communities to provide the critical care necessary for patients with diabetes and have a unique skillset that has demonstrated clear benefits in clinical and non-clinical outcomes. Here, we will provide a narrative review of the literature including the role of the pharmacist in different care models, outcomes associated with pharmacist care, and future directions and opportunities for pharmacist-managed diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.